{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:42:17Z","timestamp":1793371337101,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Ceramides are bioactive lipids that contribute to endothelial dysfunction (ED) by promoting inflammation and oxidative stress. However, whether ceramide levels are linked to peripheral microvascular endothelial function in patients with acute coronary syndrome (ACS) is not well understood. We conducted a prospective observational study of 80 ACS patients undergoing percutaneous coronary intervention at a single center. Peripheral endothelial function was assessed using the EndoPAT2000\u00ae system. ED was defined as a reactive hyperemia index &lt;1.67. Plasma ceramide species were quantified using high-performance liquid chromatography coupled with tandem mass spectrometry. The patients were stratified by ED status, ceramide level tertiles, and subgroup clinical characteristics. Multivariate logistic regression was used to determine the odds ratios and 95% confidence intervals for ED. ED was present in 57.5% of the patients. No significant differences were observed in age, gender, traditional cardiovascular risk factors, or lipid parameters between ED and non-ED groups. Among the 7 ceramide species analyzed, cer (d18:1\/24:0) was significantly elevated in the ED group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.045). Cer (d18:1\/24:0) was independently associated with ED (odds ratios\u2005=\u20052.83; 95% confidence intervals: 1.08\u20137.44;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.034). Reactive hyperemia index values declined across tertiles of cer (d18:1\/24:0) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend\u2005=\u2005.03). Among patients on standard medications such as statins, \u03b2-blockers, or angiotensin-converting enzyme inhibitors (ACEI)\/ARB) therapy, cer (d18:1\/24:0) levels were still markedly higher in those with ED than in those without (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Plasma cer (d18:1\/24:0) is independently associated with impaired endothelial function in ACS patients. Its elevated levels in patients with ED despite receiving standard cardiovascular therapies suggest its potential role in residual ED and indicate its value as a candidate biomarker for vascular risk stratification.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048341","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:01:57Z","timestamp":1776434517000},"page":"e48341","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Association between plasma ceramide levels and endothelial dysfunction in patients with acute coronary syndrome: A prospective observational study"],"prefix":"10.1097","volume":"105","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[{"name":"Medical School of Chinese PLA, Beijing, China"},{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"},{"name":"The Second Medical School of Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxuan","family":"Cai","sequence":"additional","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical School of Chinese PLA, Beijing, China"},{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical School of Chinese PLA, Beijing, China"},{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Wei","sequence":"additional","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"},{"name":"The Medical School of Nankai University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"},{"name":"Department of Cardiology, The First Medical Center of PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-9375","authenticated-orcid":false,"given":"Yundai","family":"Chen","sequence":"additional","affiliation":[{"name":"Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China"},{"name":"Department of Cardiology, The First Medical Center of PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","article-title":"The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.","volume":"405","author":"Zaman","year":"2025","journal-title":"Lancet"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(21)02391-6","article-title":"Acute coronary syndromes.","volume":"399","author":"Bergmark","year":"2022","journal-title":"Lancet"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2023.01.079","article-title":"Endothelial dysfunction predicts bleeding and cardiovascular death in acute coronary syndrome.","volume":"376","author":"Yoshii","year":"2023","journal-title":"Int J Cardiol"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.117.309813","article-title":"Endothelial functions.","volume":"37","author":"Godo","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacasi.2024.09.015","article-title":"Noninvasive assessment of vascular function: from physiological tests to biomarkers.","volume":"4","author":"Higashi","year":"2024","journal-title":"JACC Asia"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"e003202","DOI":"10.1161\/JAHA.116.003202","article-title":"Impaired peripheral endothelial function assessed by digital reactive hyperemia peripheral arterial tonometry and risk of in-stent restenosis.","volume":"5","author":"Komura","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000522098","article-title":"Noninvasive investigation of the presence and extent of coronary artery disease by the evaluation of fingertip-reactive hyperemia.","volume":"31","author":"Fatihoglu","year":"2022","journal-title":"Med Princ Pract"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"232","DOI":"10.14336\/AD.2021.0710","article-title":"Emerging roles of ceramide in cardiovascular diseases.","volume":"13","author":"Shu","year":"2022","journal-title":"Aging Dis"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/antiox12010143","article-title":"Sphingolipids and atherosclerosis: the dual role of ceramide and sphingosine-1-phosphate.","volume":"12","author":"Piccoli","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12265-020-09978-3","article-title":"Plasma ceramides in relation to coronary plaque characterization determined by optical coherence tomography.","volume":"14","author":"Pan","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.diabet.2019.07.006","article-title":"Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography.","volume":"46","author":"Mantovani","year":"2020","journal-title":"Diabetes Metab"},{"key":"R13-20260605","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jacl.2025.09.002","article-title":"Joint association of plasma ceramide and renal function with coronary artery lesion severity: the CRUISE-MET study.","volume":"19","author":"Chen","year":"2025","journal-title":"J Clin Lipidol"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"e14359","DOI":"10.1111\/eci.14359","article-title":"Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure.","volume":"55","author":"Witoslawska","year":"2025","journal-title":"Eur J Clin Invest"},{"key":"R15-20260605","doi-asserted-by":"crossref","first-page":"104206","DOI":"10.1016\/j.numecd.2025.104206","article-title":"A new plasma ceramide 24-based risk score predicts overall mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease.","volume":"35","author":"Mantovani","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R16-20260605","doi-asserted-by":"crossref","first-page":"e022852","DOI":"10.1161\/JAHA.121.022852","article-title":"Plasma ceramide levels are elevated in patients with early coronary atherosclerosis and endothelial dysfunction.","volume":"11","author":"Akhiyat","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R17-20260605","doi-asserted-by":"crossref","first-page":"100181","DOI":"10.1016\/j.jvssci.2023.100181","article-title":"Ceramides in peripheral arterial plaque lead to endothelial cell dysfunction.","volume":"4","author":"Meade","year":"2023","journal-title":"JVS Vasc Sci"},{"key":"R18-20260605","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/HYPERTENSIONAHA.120.15721","article-title":"Vascular effects of ACE (Angiotensin-Converting Enzyme) inhibitors and statins in adolescents with type 1 diabetes.","volume":"76","author":"Chiesa","year":"2020","journal-title":"Hypertension"},{"key":"R19-20260605","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.2147\/DDDT.S135173","article-title":"High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction.","volume":"11","author":"Gavazzoni","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"R20-20260605","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2169\/internalmedicine.0701-17","article-title":"The SGLT2 inhibitor dapagliflozin significantly improves the peripheral microvascular endothelial function in patients with uncontrolled type 2 diabetes mellitus.","volume":"57","author":"Sugiyama","year":"2018","journal-title":"Intern Med"},{"key":"R21-20260605","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R22-20260605","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R23-20260605","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","article-title":"Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.","volume":"9","author":"Lu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R24-20260605","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3399\/bjgp20X708053","article-title":"Diagnosis and management of hypertension in adults: NICE guideline update 2019.","volume":"70","author":"Jones","year":"2020","journal-title":"Br J Gen Pract"},{"key":"R25-20260605","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.118.11554","article-title":"Physiological diagnostic criteria for vascular failure.","volume":"72","author":"Tanaka","year":"2018","journal-title":"Hypertension"},{"key":"R26-20260605","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma ceramides.","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R27-20260605","doi-asserted-by":"crossref","first-page":"e015258","DOI":"10.1161\/JAHA.119.015258","article-title":"Prediction of residual risk by ceramide-phospholipid score in patients with stable coronary heart disease on optimal medical therapy.","volume":"9","author":"Hilvo","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R28-20260605","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"key":"R29-20260605","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/ijms20020411","article-title":"Ceramide and regulation of vascular tone.","volume":"20","author":"Cogolludo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R30-20260605","doi-asserted-by":"crossref","first-page":"e39206","DOI":"10.1016\/j.heliyon.2024.e39206","article-title":"Plasma C24:0 ceramide impairs adipose tissue remodeling and promotes liver steatosis and glucose imbalance in offspring of rats.","volume":"10","author":"Camacho-Morales","year":"2024","journal-title":"Heliyon"},{"key":"R31-20260605","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1194\/jlr.S092874","article-title":"Advances in determining signaling mechanisms of ceramide and role in disease.","volume":"60","author":"Stith","year":"2019","journal-title":"J Lipid Res"},{"key":"R32-20260605","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J"},{"key":"R33-20260605","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurjpc\/zwaa143","article-title":"Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.","volume":"29","author":"Gencer","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"R34-20260605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11883-025-01284-0","article-title":"Beyond cholesterol: unraveling residual lipidomic risk in cardiovascular health.","volume":"27","author":"Campbell","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"R35-20260605","doi-asserted-by":"crossref","first-page":"e1015","DOI":"10.1016\/j.jacl.2024.07.009","article-title":"The relationship between ceramide profile and residual inflammatory risk in patients with coronary artery disease: insights from a prospective study.","volume":"18","author":"Zhang","year":"2024","journal-title":"J Clin Lipidol"},{"key":"R36-20260605","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"R37-20260605","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.numecd.2022.06.020","article-title":"Relationship between PCSK9 and endothelial function in patients with acute myocardial infarction.","volume":"32","author":"Cimaglia","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:00:53Z","timestamp":1780675253000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":37,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048341","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2025-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}